Identification of 19 New Metabolites Induced by Abnormal Amino Acid Conjugation in Isovaleric Acidemia

Budd MA, Tanaka K, Holmes LB, Efron ML, Crawford JD, Isselbacher KJ. Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism. N Engl J Med1967;277:321-327.

Naglak M, Salvo R, Madsen K, Dembure P, Elsas L. The treatment of isovaleric acidemia with glycine supplement. Pediatr Res1988;24:9-13.

Tanaka K, Rosenberg LE. Disorders of branched chain amino acid and organic acid metabolism. Stanbury JB Wyngaarden JB Fredrickson DS Goldstein JL Brown MS eds. The metabolic bases of inherited disease, 5th ed1982:440-473 McGraw-Hill New York. .

Sweetman L, Williams JC. Branched chain organic acidurias. Schriver CR Beaudet AL Sly WS Valle D eds. Metabolic and molecular bases of inherited disease, 7th ed1995:791-801 McGraw-Hill New York. .

Tanaka K, Orr JC, Isselbacher KJ. The identification of β-hydroxyisovaleric acid in the urine of a patient with isovaleric acidemia. Biochem Biophys Acta1968;152:638-641.

Tanaka K, Ikeda Y, Matsubara Y, Hyman D. Molecular basis of isovaleric acidemia in the study of the acyl-CoA dehydrogenase family. Adv Neurol1988;48:107-131.

Truscott RJ, Malegan D, McCairns E, Burke D, Hick L, Sims P, et al. New metabolites in isovaleric acidemia. Clin Chim Acta1981;110:187-203.

Hine DG, Tanaka K. The identification and the excretion pattern of isovaleryl glucoronide in the urine of patients with isovaleric acidemia. Pediatr Res1984;18:508-513.

Lehnert W. Excretion of N-isovalerylglutamic acid in isovaleric acidemia. Clin Chim Acta1981;116:249-253.

Lehnert W. N-Isovalerylalanine and N-isovalerylsarcosine: two new metabolites in isovaleric acidemia. Clin Chim Acta1983;134:207-212.

Millington DS, Roe CR, Maltby DA, Inoue F. Endogenous catabolism is the major source of toxic metabolites in isovaleric acidemia. J Pediatr1987;110:56-60.

Lehnert W. 3-Hydroxyisoheptanoic acid: a new metabolite in isovaleric acidemia. Clin Chim Acta1981;113:101-103.

Chalmers RA, Lawson AM. Organic acids in man: analytical chemistry, biochemistry and diagnosis of the organic acidurias1982:523pp Chapman and Hall New York. .

Duran M, Bruinvis L, Ketting D, Kamerling JP, Wadman SK, Schutgens RBH. The identification of E-2-methylgutaconic acid, a new isoleucine metabolite, in the urine of patients with β-ketothiolase deficiency, propionic acidemia and methylmalonic acidemia. Biomed Mass Spectrom1982;9:1-5.

Hagenfeldt L, Naglo AS. New conjugated urinary metabolites in intermediate-type maple syrup urine disease. Clin Chim Acta1987;169:77-83.

Liebich HM, Först C. Urinary excretion of N-acetylamino acids. J Chromatogr1985;338:187-191.

Loots DT, Mienie LJ, Bergh JJ, van der Schyf CJ. Acetyl-l-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat. Life Sci2004;75:1243-1253.

Van der Westhuizen FH, Pretorius PJ, Erasmus E. The utilization of alanine, glutamic acid, and serine as amino acid substrates for glycine N-acyltransferase. J Biochem Mol Toxicol2000;14:102-109.